BioClinica, a provider of clinical trial management services, announced that Mundipharma Research, a pharmaceutical research and development company, has selected BioClinica's OnPoint CTMS (clinical trial management system). With this ...
Tags: CTMS, Mundipharma Research, BioClinica, SharePoint
Mundipharma and Northlake International have joined forces to develop structurally new next generation alkylating agents to treat haematological malignancies. Under the $84.5m agreement, Mundipharma and its independent associated ...
Tags: Alkylating Agents, haematological malignancies, alkylation efficiency